The workgroup approved 6 measures: (1) Annual cognitive health assessment for patients ≥ 65 years and for patients with neurologic illnesses at any age (2) Cognitive and functional assessment for patients with MCI or memory loss (3) MCI diagnosis disclosed and counseled on treatment options (4) Assessment and treatment of factors contributing to MCI (5) Avoidance of anticholinergic medications for patients with MCI (6) Education provided to care partners of patients with MCI.
Incorporating Cognivue Thrive can expand the diagnostic assessment of the patient’s overall health picture, allowing more comprehensive vision care.Dr. Michael Pier, OD.
Validity, Reliability, and Psychometric Properties of a Computerized, Cognitive Assessment Test (Cognivue)
Comparison of the Cognivue Quantitative Assessment Tool and SLUMS to Classify the Risk of Cognitive Impairment
Validation, Reliability, and Psychometric Properties of Cognivue, A Quantitative Assessment of Cognitive Impairment
Novel Computer-Based Testing Shows Multi-Domain Cognitive Dysfunction in Patients With Multiple Sclerosis
We are excited to announce that Cognivue’s peer-reviewed article, “Validity, reliability and psychometric properties of a computerized cognitive assessment” was published in the World Journal of Psychiatry (WJP). Cognivue is an important…
Sign-up to schedule a Cognivue demo!Click Here